Ocular Therapeutix, Inc
OCUL
Revenue
16.44M
▲1.67M▲11.28%
3 Months ChangeAssets
517.09M
▼-21.86M▼-4.06%
3 Months ChangeLiabilities
139.40M
▲8.43M▲6.44%
3 Months ChangeFree Cash Flow
-34.14M
▼-10.79M▼-46.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-09
Form 8-K
ID: 0001104659-24-107348
2024-09-03
Form 8-K
ID: 0001104659-24-096021
2024-08-07
Form 10-Q
ID: 0001558370-24-011202
2024-08-07
Form 8-K
ID: 0001104659-24-086535
2024-06-14
Form 8-K
ID: 0001104659-24-071530
2024-06-03
Form 8-K
ID: 0001104659-24-067544
2024-05-07
Form 10-Q
ID: 0001558370-24-007065
2024-05-07
Form 8-K
ID: 0001104659-24-058003
2024-04-18
Form 8-K
ID: 0001104659-24-048850
2024-03-29
Form 8-K
ID: 0001104659-24-041224